JPRN-UMIN000001547
Completed
未知
Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancer - Clinical Investigation of Bevacizumab plus FOLFIRI or FOLFOX in previously treated metastatic colorectal cancer (2nd-BV)
Tsukuba Cancer Clinical Trial Group0 sites400 target enrollmentDecember 3, 2008
Conditionscolorectal cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- colorectal cancer
- Sponsor
- Tsukuba Cancer Clinical Trial Group
- Enrollment
- 400
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Prior bevacizumab administration 2\)FOLFIRI\+bevacizumab in patients with previous CPT\-11\-based chemotherapy, or FOLFOX\+bevacizumab in patients with previous L\-OHP\-based chemotherapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of Sitopaladi Churna in the treatment of Kasa (Stable chronic Bronchitis)Health Condition 1: null- Patients suffering from Chronic Stable Bronchitis and Patients having FEV1 80%.CTRI/2017/10/010253Central Council For Research in Ayurvedic Sciences67
Completed
Not Applicable
Exploratory study for the efficacy and safety of Sansoninto on behavioral and psychological symptoms of dementia (BPSD) in patients with Dementia.: Multicenter trialDementia patients with BPSDJPRN-UMIN000021562Kanazawa University20
Completed
Not Applicable
A clinical study of the Safety and effectiveness of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) treatment for the palliation of painful bone metastasesJPRN-UMIN000012441Department of Orthopaedic Surgery, Kochi Medical School, Kochi University25
Unknown
Phase 2
Investigation of the efficacy/safety and clinical dose of TAK-390MR for Erosive Esophagitis - A Phase II/III, Stratified-Randomized, Double-Blind, Parallel-Group, Multicenter Study on Efficacy and Safety of TAK-390MR by Comparison with AG-1749 in Patients with Erosive EsophagitisSubjects endoscopically diagnosed erosive esophagitisJPRN-jRCT2080220529Takeda Pharmaceutical Company Limited850
Completed
Not Applicable
Investigation for clinical efficacy and safety of ipragliflozin 50mg and 100mg on type 2 diabetesType 2 diabetesJPRN-UMIN000016131Osaka Saiseikai Nakatsu Hospital Division of diabetes and endocrinology600